Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MSH6 |
Variant | I1109fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | MSH6 I1109fs results in a change in the amino acid sequence of the Msh6 protein beginning at aa 1109 of 1360, likely resulting in premature truncation of the functional protein (UniProt.org). I1109fs (reported as I1109fs*3) has not been biochemically characterized, but is associated with a loss of Msh6 protein expression and increased microsatellite instability in tumor samples (PMID: 14974087), and is therefore predicted to lead to a loss of Msh6 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
MSH6 mutant MSH6 inact mut MSH6 I1109fs |
Transcript | NM_000179.3 |
gDNA | chr2:g.(47803571_47803572) |
cDNA | c.(3325_3324) |
Protein | p.I1109fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001406800.1 | chr2:g.(47803571_47803572) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
XM_011532798 | chr2:g.(47804978_47804979) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
NM_001406808.1 | chr2:g.(47803571_47803572) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
NM_001281492 | chr2:g.(47806271_47806272) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
XM_024452819.1 | chr2:g.(47803571_47803572) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
XM_024452820.1 | chr2:g.(47804978_47804979) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
NM_000179.3 | chr2:g.(47803571_47803572) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
NM_001281492.1 | chr2:g.(47806271_47806272) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
NM_001406796.1 | chr2:g.(47803571_47803572) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
NM_001281492.2 | chr2:g.(47806271_47806272) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
NM_000179 | chr2:g.(47803571_47803572) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
NM_000179.2 | chr2:g.(47803571_47803572) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
NM_001406809.1 | chr2:g.(47803571_47803572) | c.(3325_3324) | p.I1109fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|